MC
Muppala Chengalraju Vijaya Kumar
About Muppala Chengalraju Vijaya Kumar
Data last updated:
Muppala Chengalraju Vijaya Kumar is a Director at Lablyte Technologies Private Limited (since 2023), Director at Bio Stabilix Pharma Technologies Private Limited (since 2026) and Director at Nexgen Theranostics Private Limited (since 2025). The companies operate in Food and Beverages. The largest current company by reported revenue is Lablyte Technologies Private Limited at ₹1.3 Lakh (FY 2025). Earlier, Muppala Chengalraju Vijaya Kumar was a Director at Natdrug Intermediates Private Limited (2019–2025) and Director at Acronymingredients India Private Limited (2019–2025) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lablyte Technologies Private Limited U62099KA2023PTC182656 | Director | 26 Dec 2023 | 2023 | ₹1.3 Lakh (FY 2025) | Active |
| Bio Stabilix Pharma Technologies Private Limited U21009TS2026PTC218597 | Director | 02 Jul 2026 | 2026 | Active | |
| Nexgen Theranostics Private Limited U86905KA2025PTC209748 | Director | 15 Oct 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Natdrug Intermediates Private Limited U01111KA2019PTC129174 | Director | 30 Oct 2019 | 2019 | Active | |
| Acronymingredients India Private Limited U74999KA2019PTC120087 | Director | 07 Jan 2019 | 2019 | ₹2.87 Cr (FY 2023) | Active |
| Acronymspices Llp AAQ-8659 | Designated Partner | 22 Oct 2019 | 2019 | Strike Off | |
| Biogate Associates India Private Limited U74999TN2017PTC119630 | Director | 21 Nov 2017 | 2017 | Strike Off | |
| Edxl Academy Private Limited U80904TN2017PTC119065 | Director | 13 Oct 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Muppala Chengalraju Vijaya Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Damodarareddy | 07367568 | Lablyte Technologies Private Limited | Director |
| Hari Kumar Kanchepalli | 00477441 | Lablyte Technologies Private Limited , Nexgen Theranostics Private Limited | Director |
| Chebrolu Murali Krishna | 01255657 | Bio Stabilix Pharma Technologies Private Limited | Director |
| Guntumadugu Prasad Raju | 11801771 | Bio Stabilix Pharma Technologies Private Limited | Director |
| Manoj Bhutali Bansode | 06965691 | Nexgen Theranostics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Muppala Chengalraju Vijaya Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Muppala Chengalraju Vijaya Kumar
Muppala Chengalraju Vijaya Kumar currently holds 3 directorships: Lablyte Technologies Private Limited (Director, since 26 Dec 2023, revenue ₹1.3 Lakh (FY 2025)); Bio Stabilix Pharma Technologies Private Limited (Director, since 02 Jul 2026); Nexgen Theranostics Private Limited (Director, since 15 Oct 2025).
Muppala Chengalraju Vijaya Kumar was first appointed on 13 Oct 2017 as Director at Edxl Academy Private Limited. The most recent appointment on record is 02 Jul 2026 at Bio Stabilix Pharma Technologies Private Limited.
Muppala Chengalraju Vijaya Kumar held 5 earlier board appointments: Natdrug Intermediates Private Limited (Director, 30 Oct 2019 to 05 Apr 2025); Acronymingredients India Private Limited (Director, 07 Jan 2019 to 05 Apr 2025); Acronymspices Llp (Designated Partner, from 22 Oct 2019); Biogate Associates India Private Limited (Director, from 21 Nov 2017); Edxl Academy Private Limited (Director, from 13 Oct 2017).
The current boards of Muppala Chengalraju Vijaya Kumar's companies include Damodarareddy (Lablyte Technologies Private Limited), Hari Kumar Kanchepalli (Lablyte Technologies Private Limited), Chebrolu Murali Krishna (Bio Stabilix Pharma Technologies Private Limited), Guntumadugu Prasad Raju (Bio Stabilix Pharma Technologies Private Limited), Manoj Bhutali Bansode (Nexgen Theranostics Private Limited).